Accrued Expenses and other payables

9 Months Ended

Sep. 30, 2017

Accrued Liabilities, Current [Abstract]

Accrued Expenses and other payables

6. Accrued Expenses and other payables

Accrued expenses and other payables consist of the following:

	September 30, 2017		December 31, 2016
Accrued clinical trial and other expenses	$	811,728	$	580,218
Compensation and related benefits		34,160		642,532
Deferred rent		31,775		42,423
Patent fees		35,000		40,000
Other expenses related to Pelican acquisition		82,301		—
	$	994,964	$	1,305,173

The decrease of compensation and related benefits was related to 2016 employee bonuses which were accrued at December 31, 2016 but subsequently paid in January 2017.  The increase of clinical trial and other expenses is due to the continued patient enrollment as the Company advances into Phase 2 of our HS-110 multi-arm trial.